![This shows blood in test tubes.](https://neurosciencenews.com/files/2023/08/blood-test-alzheumers-neurosce-1155x770.jpg)
Researchers have developed a two-step workflow using a new blood-based p-tau217 biomarker to improve the accuracy of Alzheimer's Disease (AD) diagnosis. The first step uses a diagnostic model that combines plasma p-tau217 with age and the APOE e4 gene to identify high-risk patients.
from Neuroscience News https://ift.tt/uSgTX87
Comments
Post a Comment